• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色素性视网膜炎患者的葡萄膜炎:30 年连续数据。

Uveitis in Patients with Retinitis Pigmentosa: 30 Years' Consecutive Data.

机构信息

a Department of Uvea , Sankara Ntethralaya , Chennai , India.

b Department of Vitreoretinal Services , Aditya Birla Sankara Nethralaya Mukundapur , Kolkata , India.

出版信息

Ocul Immunol Inflamm. 2018;26(8):1283-1288. doi: 10.1080/09273948.2017.1348527. Epub 2017 Sep 29.

DOI:10.1080/09273948.2017.1348527
PMID:28960116
Abstract

PURPOSE

To describe the clinical pattern of uveitis in patients with retinitis pigmentosa (RP) at a tertiary care eye hospital over a period of 30 years.

METHODS

The medical records of 32 eyes of 22 patients of RP with uveitis were included in this study. Collected data included age, subsets of uveitis, best corrected visual acuities (BCVA), detailed laboratory investigations, and treatment.

RESULTS

Mean age at presentation was 53.4 ± 18.8 years, and mean age of diagnosis of RP was 39.2 ± 21.4 years. Uveitis was bilateral in 10 (45.5%) patients. The most common of uveitis in current study was anterior uveitis (56.2%), followed by intermediate uveitis (43.8%). Cataract developed in 12 (37.5%) eyes, and three eyes had raised intraocular pressure. Ten patients (45.5%) required oral steroid, and one patient required oral methotrexate.

CONCLUSIONS

Uveitis in RP patients is rare, but not uncommon. Coexistence of these disorders might support the inflammatory pathway in etiology of RP.

摘要

目的

描述一家三级眼科医院在 30 年期间患有色素性视网膜炎(RP)的患者的葡萄膜炎临床特征。

方法

本研究纳入了 22 名 RP 合并葡萄膜炎患者的 32 只眼的病历。收集的数据包括年龄、葡萄膜炎亚组、最佳矫正视力(BCVA)、详细的实验室检查和治疗情况。

结果

发病时的平均年龄为 53.4±18.8 岁,RP 的平均诊断年龄为 39.2±21.4 岁。10 名患者(45.5%)的葡萄膜炎为双侧性。本研究中最常见的葡萄膜炎是前葡萄膜炎(56.2%),其次是中间葡萄膜炎(43.8%)。12 只眼(37.5%)发生白内障,3 只眼眼压升高。10 名患者(45.5%)需要口服类固醇,1 名患者需要口服甲氨蝶呤。

结论

RP 患者的葡萄膜炎罕见,但并不少见。这些疾病的并存可能支持 RP 发病机制中的炎症途径。

相似文献

1
Uveitis in Patients with Retinitis Pigmentosa: 30 Years' Consecutive Data.色素性视网膜炎患者的葡萄膜炎:30 年连续数据。
Ocul Immunol Inflamm. 2018;26(8):1283-1288. doi: 10.1080/09273948.2017.1348527. Epub 2017 Sep 29.
2
Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa.慢性葡萄膜炎中类似色素性视网膜炎的视网膜色素改变。
Graefes Arch Clin Exp Ophthalmol. 2017 Sep;255(9):1801-1810. doi: 10.1007/s00417-017-3689-7. Epub 2017 May 18.
3
The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.玻璃体内注射地塞米松植入物治疗色素性视网膜炎黄斑囊样水肿的疗效:病例报告及文献综述
Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):160-4. doi: 10.3928/23258160-20140131-03. Epub 2014 Feb 7.
4
[Retinitis pigmentosa mimicking uveitis. A case report].[伪装成葡萄膜炎的色素性视网膜炎。病例报告]
Cesk Slov Oftalmol. 2013 Mar;69(1):32-6.
5
INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA.玻璃体内注射地塞米松植入物治疗与色素性视网膜炎相关的囊样黄斑水肿。
Retina. 2018 Feb;38(2):416-423. doi: 10.1097/IAE.0000000000001542.
6
Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study.玻璃体内注射地塞米松植入物治疗色素性视网膜炎继发的顽固性黄斑囊样水肿:一项初步研究。
Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1369-1374. doi: 10.1007/s00417-017-3660-7. Epub 2017 Apr 4.
7
Ocular abnormalities in a large patient cohort with retinitis pigmentosa in Western China.中国西部一大群视网膜色素变性患者的眼部异常情况
BMC Ophthalmol. 2021 Jan 18;21(1):43. doi: 10.1186/s12886-020-01797-z.
8
Fuchs' heterochromic uveitis associated with retinitis pigmentosa.与色素性视网膜炎相关的富克斯异色性葡萄膜炎。
Acta Ophthalmol Scand. 1998 Apr;76(2):243-4. doi: 10.1034/j.1600-0420.1998.760225.x.
9
The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis.甲氨蝶呤在针对疑似潜伏性梅毒性葡萄膜炎和疑似结核相关性葡萄膜炎进行特定治疗后解决眼部炎症中的作用。
Retina. 2014 Jul;34(7):1451-9. doi: 10.1097/IAE.0000000000000080.
10
Fuchs' heterochromic cyclitis associated with retinitis pigmentosa: a family study.与色素性视网膜炎相关的富克斯异色性睫状体炎:一项家族研究。
Can J Ophthalmol. 1979 Jan;14(1):10-6.

引用本文的文献

1
Vogt-Koyanagi-Harada disease in a patient with retinitis pigmentosa in one eye and pigmented paravenous retinochoroidal atrophy in the other eye.一名患者一只眼睛患有色素性视网膜炎,另一只眼睛患有色素性视网膜脉络膜静脉旁萎缩,同时还患有伏格特-小柳-原田病。
Am J Ophthalmol Case Rep. 2025 Mar 5;38:102298. doi: 10.1016/j.ajoc.2025.102298. eCollection 2025 Jun.
2
Case Series on Autosomal Recessive Non-Syndromic Retinitis Pigmentosa Caused by POMGNT1 Mutations with a Report of a New Variant.POMGNT1突变导致的常染色体隐性非综合征性视网膜色素变性病例系列及一个新变异的报告
J Clin Med. 2023 Dec 7;12(24):7549. doi: 10.3390/jcm12247549.
3
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.
色素性视网膜炎:当前的临床管理和新兴疗法。
Int J Mol Sci. 2023 Apr 19;24(8):7481. doi: 10.3390/ijms24087481.
4
Intermediate Uveitis in Retinitis Pigmentosa Associated with a Novel Homozygous Splice Site Mutation in .色素性视网膜炎相关性中间葡萄膜炎与. 的新型纯合剪接位点突变相关。
Middle East Afr J Ophthalmol. 2022 Nov 23;29(1):59-62. doi: 10.4103/meajo.meajo_98_22. eCollection 2022 Jan-Mar.
5
Gene Mutation Ocular Phenotype.基因突变眼部表型。
Int J Mol Sci. 2022 Jul 17;23(14):7868. doi: 10.3390/ijms23147868.
6
Depletion of Retinal Dopaminergic Activity in a Mouse Model of Rod Dysfunction Exacerbates Experimental Autoimmune Uveoretinitis: A Role for the Gateway Reflex.杆状细胞功能障碍小鼠模型中视网膜多巴胺能活性耗竭加重实验性自身免疫性葡萄膜炎:门控反射的作用。
Int J Mol Sci. 2021 Dec 31;23(1):453. doi: 10.3390/ijms23010453.
7
Autosomal Recessive Bestrophinopathy: Clinical and Genetic Characteristics of Twenty-Four Cases.常染色体隐性遗传性Bestrophin病:24例临床及遗传学特征
J Ophthalmol. 2021 Apr 30;2021:6674290. doi: 10.1155/2021/6674290. eCollection 2021.
8
Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.与非感染性葡萄膜炎相关的黄斑水肿:病理生理学、病因、患病率、影响及管理挑战
Clin Ophthalmol. 2019 Sep 10;13:1761-1777. doi: 10.2147/OPTH.S180580. eCollection 2019.